Frontiers in Pharmacology | Respiratory Pharmacology

Original Research

Published on 30 Jul 2020

Anti-Bronchospasmodic Effect of JME-173, a Novel Mexiletine Analog Endowed With Highly Attenuated Anesthetic Activity

in Respiratory Pharmacology

Katharinne Ingrid Moraes Carvalho
Diego de Sá Coutinho
Humberto Cavalcante Joca
Artur Santos Miranda
Jader dos Santos Cruz
Emerson Teixeira Silva
Marcus Vinícius Nora Souza
Robson Xavier Faria
Patricia Machado Rodrigues e Silva
Jorge Carlos Santos Costa

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01159

2,546 views
2 citations

Mini Review

Published on 22 Jul 2020

Phosphodiesterase 4 Inhibitors in Allergic Rhinitis/Rhinosinusitis

in Respiratory Pharmacology

Viera Janosova
Vladimir Calkovsky
Heiko Pedan
Estera Behanova
Andrej Hajtman
Andrea Calkovska

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01135

4,322 views
10 citations

Original Research

Published on 21 Jul 2020

Quantification of Lung Fibrosis in IPF-Like Mouse Model and Pharmacological Response to Treatment by Micro-Computed Tomography

in Respiratory Pharmacology

Francesca Ruscitti
Francesca Ravanetti
Valeria Bertani
Luisa Ragionieri
Laura Mecozzi
Nicola Sverzellati
Mario Silva
Livia Ruffini
Valentina Menozzi
Maurizio Civelli

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01117

18,784 views
45 citations

Opinion

Published on 15 Jul 2020

The Post-Lockdown Era: What Is Next in Italy?

in Respiratory Pharmacology

Cristoforo Pomara
Giovanni Li Volti
Francesco Cappello

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01074

2,741 views
14 citations

Perspective

Published on 24 Jun 2020

Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy

in Respiratory Pharmacology

Ying Wang
Yang Zhang
Qian Yu
Kun Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00966

5,130 views
8 citations

Mini Review

Published on 24 Jun 2020

Pharmacotherapics Advice in Guidelines for COVID-19

in Respiratory Pharmacology

Zhang-Ren Chen
Ying Zhou
Jin Liu
Hong-Wei Peng
Jian Zhou
Hai-Li Zhong
Li-Li Liu
Ming-Fang Lai
Xiao-Hua Wei
Jin-Hua Wen

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00950

8,517 views
6 citations

General Commentary

Published on 02 Jun 2020

Commentary: “Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease” by Dankers M et al. in Frontiers in Pharmacology 2020; 10: 1519

in Respiratory Pharmacology

Harma Alma
Corina de Jong
Janwillem Kocks
Thys van der Molen

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00827

1,917 views

Mini Review

Published on 26 May 2020

Reducing the Fatality Rate of COVID-19 by Applying Clinical Insights From Immuno-Oncology and Lung Transplantation

in Respiratory Pharmacology

Fatih M. Uckun

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00796

5,740 views
14 citations

Original Research

Published on 21 May 2020

Sodium Tanshinone II Sulfonate A Ameliorates Hypoxia-Induced Pulmonary Hypertension

in Respiratory Pharmacology

Ya-Ru Bao
Jing-Wei Chen
Yan Jiang
Lin-Hui Wang
Rong Xue
Jin-Xian Qian
Guo-Xing Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00687

4,309 views
14 citations

Original Research

Published on 20 May 2020

Sinigrin Enhanced Antiasthmatic Effects of Beta Adrenergic Receptors Agonists by Regulating cAMP-Mediated Pathways

in Respiratory Pharmacology

Simeng Chu
Wenjuan Liu
Yujie Lu
Menglin Yan
Yingying Guo
Nianwei Chang
Min Jiang
Gang Bai

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00723

5,126 views
9 citations

Editorial

Published on 08 May 2020

Editorial: Drug Development and Target Discovery in Pulmonary Vascular Diseases

in Respiratory Pharmacology

Rui Zhang
Yang-Yang He
Zhi-Cheng Jing

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00660

2,566 views
2 citations

Review

Published on 06 May 2020

Respiratory Cilia as a Therapeutic Target of Phosphodiesterase Inhibitors

in Respiratory Pharmacology

Marta Joskova
Juraj Mokry
Sona Franova

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00609

11,837 views
25 citations

Original Research

Published on 06 May 2020

Inhibiting Airway Smooth Muscle Contraction Using Pitavastatin: A Role for the Mevalonate Pathway in Regulating Cytoskeletal Proteins

in Respiratory Pharmacology

Robin A. Lu
Amir A. Zeki
Sumati Ram-Mohan
Nhan Nguyen
Yan Bai
Kenneth Chmiel
Stevan Pecic
Xingbin Ai
Ramaswamy Krishnan
Chandra C. Ghosh

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00469

5,052 views
2 citations

Original Research

Published on 01 May 2020

PDE3 Inhibition Reduces Epithelial Mast Cell Numbers in Allergic Airway Inflammation and Attenuates Degranulation of Basophils and Mast Cells

in Respiratory Pharmacology

Jan Beute
Keerthana Ganesh
Hedwika Nastiti
Robin Hoogenboom
Vivica Bos
Jelle Folkerts
Marco W. J. Schreurs
Steve Hockman
Rudi W. Hendriks
Alex KleinJan

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00470

5,426 views
15 citations

General Commentary

Published on 14 Apr 2020

Commentary: Ultrasound-Guided Biopsy of Pleural-Based Pulmonary Lesions by Injection of Contrast-Enhancing Drugs

in Respiratory Pharmacology

Carla Maria Irene Quarato
Salvatore De Cosmo
Federica D'Agostino
Giulia Gaudiuso
Marco Sperandeo

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00365

2,151 views
2 citations

Original Research

Published on 19 Mar 2020

Suppression of NLRP3 Inflammasome by Erythropoietin via the EPOR/JAK2/STAT3 Pathway Contributes to Attenuation of Acute Lung Injury in Mice

in Respiratory Pharmacology

Fei Cao
Xinyi Tian
Zhongwang Li
Ya Lv
Jun Han
Rong Zhuang
Bihuan Cheng
Yuqiang Gong
Binyu Ying
Shengwei Jin

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00306

9,064 views
58 citations

Navigation group

Articles

Anti-Bronchospasmodic Effect of JME-173, a Novel Mexiletine Analog Endowed With Highly Attenuated Anesthetic Activity

Phosphodiesterase 4 Inhibitors in Allergic Rhinitis/Rhinosinusitis

Quantification of Lung Fibrosis in IPF-Like Mouse Model and Pharmacological Response to Treatment by Micro-Computed Tomography

The Post-Lockdown Era: What Is Next in Italy?

Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy

Pharmacotherapics Advice in Guidelines for COVID-19

Commentary: “Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease” by Dankers M et al. in Frontiers in Pharmacology 2020; 10: 1519

Reducing the Fatality Rate of COVID-19 by Applying Clinical Insights From Immuno-Oncology and Lung Transplantation

Sodium Tanshinone II Sulfonate A Ameliorates Hypoxia-Induced Pulmonary Hypertension

Sinigrin Enhanced Antiasthmatic Effects of Beta Adrenergic Receptors Agonists by Regulating cAMP-Mediated Pathways

Editorial: Drug Development and Target Discovery in Pulmonary Vascular Diseases

Respiratory Cilia as a Therapeutic Target of Phosphodiesterase Inhibitors

Inhibiting Airway Smooth Muscle Contraction Using Pitavastatin: A Role for the Mevalonate Pathway in Regulating Cytoskeletal Proteins

PDE3 Inhibition Reduces Epithelial Mast Cell Numbers in Allergic Airway Inflammation and Attenuates Degranulation of Basophils and Mast Cells

Commentary: Ultrasound-Guided Biopsy of Pleural-Based Pulmonary Lesions by Injection of Contrast-Enhancing Drugs

Suppression of NLRP3 Inflammasome by Erythropoietin via the EPOR/JAK2/STAT3 Pathway Contributes to Attenuation of Acute Lung Injury in Mice